BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Income Statement
TSX:BCT • CA1079303071
5.41 CAD
-0.23 (-4.08%)
Last: Feb 20, 2026, 07:00 PM
| TTM (2025-10-31) | 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 297.90K | 244.30K | 140.10K | N/A | N/A | |||
| Operating Expenses | 30.37M | 27.20M | 33.33M | 23.27M | 15.29M | |||
| Research and Development | 24.29M | 21.27M | 27.18M | 15.34M | 8.02M | |||
| Selling, General, and Administrative Expenses | 6.09M | 5.93M | 6.15M | 7.94M | 7.27M | |||
| Operating Income | -30.37M | -27.20M | -33.33M | -23.27M | -15.29M | |||
| Interest Income/Expense | 1.37M | 648.70K | 28.40M | 2.97M | -11.55M | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 3.40K | |||
| Income Before Taxes | -29.01M | -26.56M | -4.93M | -20.30M | -26.84M | |||
| Net Income | -28.71M | -26.31M | -4.79M | -20.30M | -26.84M | |||
| EBITDA | -30.27M | -27.10M | -33.25M | -23.26M | -15.27M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -53.28 | -62.19 | -43.68 | -194.96 | -259.82 | |||
| Non GAAP EPS | N/A | -128.19 | -45.00 | -195.00 | N/A | |||
| Statistics | ||||||||
All data in USD